High-Energy Laser in the Conservative Treatment of Rhizarthrosis
Recruiting · NCT07566507 · Interventional (participants receive a specific treatment) · Lead sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
View the official record on ClinicalTrials.gov →Interventions studied
THEAL:Ixyon XP (Mectronic, Bergamo, Italy)
What this trial is about
Osteoarthritis (OA) is a degenerative joint disease that can affect the hands and is particularly debilitating when it involves the trapeziometacarpal joint (rhizarthrosis). It causes pain, deformity, limited movement and strength, joint instability, resulting in significant limitations in daily activities.Many conservative treatments, such as medications, therapeutic exercises, physical therapy, and orthoses, are effective for managing hand OA. For patients who do not respond to conservative treatments, surgical intervention will be necessary.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- arthrosis of the trapezoid-metacarpal with stage 1 or 2 of the Eaton-Littler radiographic classification and pain (recent radiograph within 6 months previously);
- clinical picture that has been occurring for at least 6 months;
- pain scored with VAS scale at least 4/10.
Exclusion criteria
- rheumatoid arthritis or outcomes of trauma in the affected area, contra-indications to treatment with laser therapy (neoplasia, pregnancy, thrombocytopenia, epilepsy, uncompensated heart disease or arrhythmia, pacemaker, local infections),
- corticosteroid infiltration or physical therapy in the previous 4 weeks.
Where it is running
1 location listed.
- Angela Notarnicola - Bari, Italy